Preauthorization Slows Treatment; Taxing Cancer Away; HPV Saliva Test

Prescriptions for most anticancer drugs require prior authorization, which increases the time until patients begin receiving the drugs. (ASCO Quality Care Symposium)

Exelixis announced FDA approval of cabozantinib (Cabometyx) for children and adults with radioactive iodine-refractory, locally advanced/metastatic differentiated thyroid cancer previously treated with VEGF receptor-targeted therapy.

Seagen and Genmab announced FDA accelerated approval of tisotumab vedotin (Tivdak) for recurrent/metastatic cervical cancer previously treated with chemotherapy.

Doubling taxes on alcohol could reduce consumption and substantially reduce the number of alcohol-related cancers and cancer deaths. (Lancet Regional Health)

The FDA authorized a form of artificial intelligence to aid pathologists in evaluating prostate biopsies for cancer.

Incyte announced FDA approval of ruxolitinib (Jakafi) for chronic graft-versus-host disease.

Triple-negative breast cancer — the most aggressive and difficult-to-treat breast cancer — occurs three times as often in Black women as in white women. (Penn Medicine, Cancer Medicine)

A simple saliva test has shown promise as an aid to early diagnosis of oropharyngeal cancer associated with human papillomavirus. (Journal of Molecular Diagnostics)

Radiation therapy for cancer in the left breast more than doubled women’s risk of developing coronary artery disease. (JACC: CardioOncology)

Men with prostate cancer value careful, timely, and sensitive communication from healthcare providers, according to a survey of patients and their caregivers. (European Journal of Cancer Care)

A Delaware judge ruled that Japanese pharma giant Takeda broke a contract with AbbVie by not supplying the U.S. partner with the prostate cancer drug leuprolide as stipulated in the contract. (FiercePharma)

  • author

    Charles Bankhead is senior editor for oncology and also covers urology, dermatology, and ophthalmology. He joined MedPage Today in 2007. Follow

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Everything You Need to Know About the Keto Diet for Beginners thumbnail

Everything You Need to Know About the Keto Diet for Beginners

THE KETOGENIC DIET has powered everything from celebrity cookbooks, to Instagram influencers to macro-tracking apps. To say the Keto market is booming is an understatement—and it's not slowing down any time soon. From its humble beginnings in the 1920s, our perception of the diet has changed dramatically—it's been seen as a treatment for epilepsy (yes
Read More
Hand strikes head... 6-year-old boy who was beaten for a long time, the director also attempted to conceal the incident [Video] thumbnail

Hand strikes head… 6-year-old boy who was beaten for a long time, the director also attempted to conceal the incident [Video]

6세 아동에 위협·폭행한 어린이집 보육교사 CCTV 영상. YTN 보도화면 캡처 6세 아동에 위협·폭행한 어린이집 보육교사 CCTV 영상. YTN 보도화면 캡처 경북 포항의 한 어린이집 보육교사가 6세 남아를 장기간 폭행한 사건이 알려져 공분을 사고 있다. 아이는 심리치료 20회가 필요하다는 진단을 받고, 현재 아동심리치료센터를 방문해 치료를 받고 있는 것으로 알려졌다. 25일 YTN은 보도를 통해 피해 아동이 지난 6월부터 목과 팔에 상처를…
Read More
Vitality X Apple & Date Bircher thumbnail

Vitality X Apple & Date Bircher

Vitality X Apple & Date Bircher By: The WellBeing Team Adding JSHealth’s Vitality X glow powder to a classic Bircher muesli offers a seriously delicious result! This Bircher is perfect for meal prep; simply double or triple the recipe. Ingredients 1 serve JSHealth Vitality X ⅔ cup water ½ cup rolled oats ½ tbsp pepitas…
Read More
תעלומת נגיף הקורונה thumbnail

תעלומת נגיף הקורונה

בסוף החודש שעבר, קהילת המודיעין האמריקאית דיווחה שאין ברשותה מספיק מידע כדי להכריע האם מקור נגיף הקורונה במעבדה בסין. גורמים רשמיים בארה"ב אמרו שרק סין יכולה לסייע בפתרון השאלות בנוגע למקורו האמיתי של הנגיף שהרג עד עתה יותר מ-4.5 מיליון בני אדם ברחבי העולם, אם תספק מידע כמו דגימות קליניות ונתונים אפידמיולוגיים על המקרים המוקדמים…
Read More
Index Of News
Consider making some contribution to keep us going. We are donation based team who works to bring the best content to the readers. Every donation matters.
Donate Now

Liking our Index Of News so far? Would you like to subscribe to receive news updates daily?